$A wide range of infectious disease ELISA kits and reagents made by Virion\Serion is available from benchmark antibodies$

Measles Virus IgG ELISA kit-SERION <i>classic</i> ESR102G - Image 2

Measles Virus IgG ELISA kit-SERION classic ESR102G

$364.00

Summary

Virion/Serion Diagnostic Kit for research use (RUO)
Measles Virus IgG ELISA Kit
Suitable for IgG detection
Ready-to-use
96 tests

SKU: ESR102G Category: Virion/Serion kits Tags: ELISA, Measles Virus

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Human Measles Virus reactive IgG
species reactivity	Measles Virus
applications	ELISA
assay type	Indirect & quantitative
available sizes	96 tests

Measles Virus IgG ELISA Kit ESR102G

Assay type
Indirect ELISA

Overview
The SERION ELISA classic Masern/Measles Virus IgG and IgM tests are quantitative and qualitative immunoassays for the detection of human antibodies in serum or plasma directed against Measles Virus. The SERION ELISA classic Masern/Measles Virus IgM test is recommended for the determination of acute infections. The SERION ELISA classic Masern/Measles Virus IgG assay is recommended for determination of immune status and for detection of intrathecal synthesized IgG antibodies in cerebrospinal fluid for CSF diagnostics.

Research area
Infectious Disease

Sample type
Serum, plasma, whole blood

Components

Break apart microtiter test strips each with antigen coated single wells	8 x 12 (96 Total)
Standard serum (ready-to-use)	2 x 2 mL
Negative control serum (ready-to-use)	2 mL
Anti-human-IgG-conjugate (ready-to-use)	13 mL
Washing solution concentrate (sufficient for 1000ml)	33.3 mL
Dilution buffer	2 x 50 mL
Stopping solution	15 mL
Substrate (ready-to-use)	13 mL
Quality control certificate with standard curve and evaluation table	1

Storage
2-8°C

Associated products
Measles Antigen (BA102VS)
Measles Virus IgG Control Serum (BC102G)
Measles Virus IgM ELISA Kit (ESR102M)
Measles Virus IgM Control Serum (BC102M)
Measles Antigen [premium] (BA102VS-S)

Additional information
Additional Serion Kit Information

target relevance

human antibody anti-Measles Virus

Measles Virus

Description
Virus that causes measles (rubeola)

Structure
Measles virus is an enveloped, negative-sense, single-stranded RNA virus belonging to the genus Morbillivirus within the family Paramyxoviridae. Humans are the only known natural reservoir of the virus. The viral particle contains a lipid envelope with fusion (F) and hemagglutinin (H) glycoproteins that mediate attachment to and entry into host cells. Measles virus is one of the most contagious human pathogens known and is transmitted primarily through respiratory droplets and airborne aerosols. Following infection, the virus initially replicates in the respiratory tract and regional lymphoid tissues before disseminating systemically. Measles virus can induce transient but profound immune suppression, increasing susceptibility to secondary infections for weeks to months after recovery. Widespread vaccination has dramatically reduced disease incidence in many regions, although outbreaks continue to occur where vaccination coverage is insufficient.

Diagnosis
The diagnosis of measles virus infection is performed through serological and molecular methods. Detection of measles-specific IgM antibodies by ELISA is commonly used to confirm recent infection, while IgG antibody testing may be used to assess immune status or evidence of prior exposure. Reverse transcription polymerase chain reaction (RT-PCR) provides highly sensitive detection of viral RNA in respiratory specimens, throat swabs, nasopharyngeal samples, urine, and blood and is particularly useful during the early phase of infection. Viral genotyping may be performed for epidemiological investigations and outbreak surveillance. Laboratory confirmation is important because clinical symptoms can resemble those of other viral exanthematous illnesses.

Symptoms
Measles virus infection typically develops following an incubation period of approximately seven to fourteen days. Early symptoms include high fever, cough, coryza (runny nose), conjunctivitis, malaise, and characteristic Koplik spots on the oral mucosa. Several days later, a maculopapular rash appears, beginning on the face and spreading downward to the trunk and extremities. Additional symptoms may include headache, fatigue, loss of appetite, and lymphadenopathy. Although most individuals recover completely, severe complications can occur, particularly in young children, malnourished individuals, pregnant women, and immunocompromised patients. Complications include otitis media, pneumonia, diarrhea, encephalitis, and the rare but fatal neurological disorder subacute sclerosing panencephalitis (SSPE). Measles remains a significant cause of vaccine-preventable morbidity and mortality worldwide.

Data

FAQ & Publications

Frequently Asked Questions

What types of samples can be analyzed with the Measles Virus IgG ELISA Kit ESR102G?

This ELISA kit is suitable for testing human serum, plasma, and whole blood samples for the presence of Measles Virus reactive IgG antibodies.

How should the Measles Virus IgG ELISA Kit ESR102G be stored to maintain stability?

The kit components should be stored at a temperature between 2 to 8 degrees Celsius to ensure proper stability and performance.

What is the principle behind the detection method used in the Measles Virus IgG ELISA Kit ESR102G?

The kit employs an indirect and quantitative ELISA assay format to detect human IgG antibodies reactive to Measles Virus antigens coated on microtiter wells.

Can the Measles Virus IgG ELISA Kit ESR102G be used for cerebrospinal fluid (CSF) diagnostics?

Yes, this kit is recommended for detecting intrathecal synthesized IgG antibodies in cerebrospinal fluid, which is useful in CSF diagnostics for conditions such as encephalitis and multiple sclerosis.

Publications

pmid	title	authors	citation
41455185	Assessing vaccination coverage and antibody levels for measles, pertussis, and tetanus in Boende, DR Congo: Implications for maternal and child health.	Maha Salloum, Leen Vandermosten, Tafadzwa Maseko, Solange Milolo, Ynke Lariviere, Trésor Zola Matuvanga, Freddy Bikioli Bolombo, Vivi Maketa Tevuzula, Hypolite Muhindo-Mavoko, Antea Paviotti, Hilde Bastiaens, Pierre Van Damme, Isabelle Desombere, Jean-Pierre Van Geertruyden, Patrick Mitashi	Vaccine 73:128083
41240950	Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.	Birahim Pierre Ndiaye, Lucy Koech, Laina D Mercer, John J Aponte, Badara Cisse, Faith Riziki, Winnie Keter, Niles Eaton, Siry Diye, Djibril Wade, Ndeye Sakha Bob, Mike G Raine, Howard Her, Sookyung Kim, Rahsan Erdem, Chankyu Lee, Frederick J Cassels, Youngran Park, Moussa Dia, Yeong Ok Baik, Gamou Fall, Emily Locke, Patricia W Njuguna	Lancet Glob Health 13:e2122-e2132
41106800	Associations between serum metals and antibody levels against measles, rubella, and varicella vaccines in children with sex-specific nonlinear patterns.	Mei Liu, Pingting Zhu, Fenfang Deng, Boheng Liang, Yang Xu, Pengzhe Qin, Rongfei Peng, Lei Tan	Environ Pollut 386:127276
40912534	Spatial disparities in perfluoroalkyl and polyfluoroalkyl substances exposure and immunosuppressive effects on vaccine induced antibody levels in Guangzhou children.	Zhimei Mou, Pingting Zhu, Fenfang Deng, Yang Xu, Pengzhe Qin, Rongfei Peng, Juntao Li, Lei Tan	Environ Pollut 385:127066
39203968	A Serological Survey of Measles and Rubella Antibodies among Different Age Groups in Eastern China.	Rui Yan, Hanqing He, Xuan Deng, Yang Zhou, Xuewen Tang, Yao Zhu, Hui Liang, Yaping Chen, Mengya Yang, Yuxia Du, Can Chen, Jiaxin Chen, Shigui Yang, Ridphe Group	Vaccines (Basel) 12:N/A

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
ESR102G protocol

Documents

#
EO0198	Safety Data Sheet	QC certificate
EP0242	Safety Data Sheet	QC certificate
EQ0056	Safety Data Sheet	QC certificate
EQ0169	Safety Data Sheet	QC certificate
EQ0188	Safety Data Sheet	QC certificate
EQ0240	Safety Data Sheet	QC certificate

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Measles Virus IgG ELISA kit-SERION classic ESR102G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Measles Virus IgM ELISA kit-SERION classic ESR102M

Elotuzumab ELISA kit 60789

Sacituzumab govitecan (anti-TROP2) ELISA Kit 60790

Chicken IgY ELISA Kit 50033

Brolucizumab ELISA kit 60794

Rabbit IgG ELISA Kit 50034

Infliximab ELISA Kit 62000

Goat IgG ELISA Kit 50035

Adalimumab ELISA Kit 62001

Human TNFA ELISA Kit 50037

GFP ELISA Kit 50036

Rituximab ELISA Kit 60045

Anti-Abciximab antibody ELISA Kit 60155

Anti-Tezepelumab antibody ELISA Kit 60787

Anti-Emicizumab antibody ELISA Kit 60788